Wei-Yong R, Ming-Yuan B, Wei-Wei F, Yu-Jun W, Wei-Quan B, Ling L

Language: English
References: 15
Page: 105-111
PDF size: 280.35 Kb.

ABSTRACT

Background: Neonatal necrotizing enterocolitis is a common and often fatal gastrointestinal disease, especially in premature infants. To study potential mechanisms underlying the protective effect of breast milk on neonatal necrotizing enterocolitis, we induced intestinal inflammation in a Caco-2 cell model of neonatal necrotizing enterocolitis by hypoxia/re-oxygenation to investigate whether breast milk supernatant fluid inhibited the expression of proinflammatory cytokines interleukin-1β, interleukin-6, and tumor necrosis factor-α. Methods: Caco-2 cells were divided into normal (control) and neonatal necrotizing enterocolitis groups. Neonatal necrotizing enterocolitis was mimicked by exposing Caco-2 cells to hypoxia/re-oxygenation. Cells were independently maintained in minimal essential medium alone, minimal essential medium containing 5% breast milk supernatant, or 5% boiled breast milk supernatant. Production of interleukin-1β, interleukin-6, and tumor necrosis factor-α was investigated in cell culture supernatants by ELISA, reverse transcription polymerase chain reaction, and immunofluorescence. Results: Hypoxia/ re-oxygenation significantly increased the expression of interleukin-1β, interleukin-6, and tumor necrosis factor-α. In the normal group, breast milk supernatant and boiled breast milk supernatant markedly downregulated the expression of interleukin-1β, interleukin-6, and tumor necrosis factor-α when compared with the minimal essential medium group, with the reduction in interleukin-1β expression being more pronounced in the breast milk group. In Caco-2 cells undergoing hypoxia/re-oxygenation, both breast milk supernatant and boiled breast milk supernatant significantly reduced the expression of interleukin-1β, interleukin-6, and tumor necrosis factor-α, where the decrease in interleukin-1β expression was greater in the breast milk group. Conclusions: Breast milk supernatant fluid inhibited the expression of proinflammatory cytokines interleukin-1β, interleukin-6, and tumor necrosis factor-α in Caco-2 cells, especially after hypoxia/re-oxygenation. This may be one of the mechanisms underlying the protective effect of breast milk on neonatal necrotizing enterocolitis.

REFERENCES

1. Hans Van G, Chen C, Zhang R. Hot points at necrotic enterocolitis in newborns. Chin J Evi Bas Pedia. 2011;06:321-3.

2. Dilli D, Eras Z, Ulu HÖ, Dilmen U, S¸akrucu ED. Does necrotizing enterocolitis affect growth and neurodevelopmental outcome in very low birth weight infants? Pediatr Surg Int. 2012; 28:471-6.

3. Karatepe HO, Kilincaslan H, Berber M, et al. The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis. Pediatr Surg Int. 2014;30:327-32.

4. Yurttutan S, Ozdemir R, Canpolat FE, et al. Beneficial effects of Etanercept on experimental necrotizing enterocolitis. Pediatr Surg Int. 2014;30:71-7.

5. McElroy SJ, Prince LS, Weitkamp J-H, Reese J, Slaughter JC, Polk DB. Tumor necrosis factor receptor 1-dependent depletion of mucus in immature small intestine: a potential role in neonatal necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2011;301:G656-66.

6. Richter JM, Schanbacher BL, Huang H, Xue J, Bauer JA, Giannone PJ. Lipopolysaccharide binding protein enables intestinal epithelial restitution despite lipopolysaccharide exposure. J Pediatr Gastroenterol Nutr. 2012;54:639.

7. Geng Y, Li J, Wang F, et al. Epidermal growth factor promotes proliferation and improves restoration after intestinal ischemiareperfusion injury in rats. Inflammation. 2013;36:670-9.

8. Gane B, Bhat BV, Adhisivam B, et al. Risk factors and outcome in neonatal necrotising enterocolitis. Indian J Pediatr. 2014; 81:425-8.

9. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125:921-30.

10. Kasivajjula H, Maheshwari A. Pathophysiology and current management of necrotizing enterocolitis. Indian J Pediatr. 2014; 81:489-97.

11. Sun BW, Zhao XC, Wang GJ, Li N, Li JS. Changes in biological function of dipeptide transporter in Caco-2 cells treated with normal and hypoxia/reoxygenation and regulatory effects of growth hormone. Med J Chin Peo Lib Army. 2003;28: 1025-7.

12. Gregory KE, Walker WA. Immunologic factors in human milk and disease prevention in the preterm infant. Curr Pediatr Rep. 2013; 1:222-8.

13. Herrmann K, Carroll K. An exclusively human milk diet reduces necrotizing enterocolitis. Breastfeed Med. 2014;9:184-90.

14. Winterberg T, Vieten G, Feldmann L, et al. Neonatal murine macrophages show enhanced chemotactic capacity upon tolllike receptor stimulation. Pediatr Surg Int. 2014;30:159-64.

15. Liu YY, Fatheree NY, Mangalat N, Rhoads JM. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol. 2012;302:G608-17.